China Releases Interpretations Of Criminal Activities Associated With Counterfeit Drugs
This article was originally published in PharmAsia News
At a recent press conference by China's State Council Information Office, top executives from the People's Supreme Court and Procuratorate introduced the background, procedures and main content on the interpretation draft of the law against counterfeit and inferior medicines. Officially enforced on May 27, the legal application seeks to improve the criteria for determining the crimes of: production and sale of counterfeit drugs that are seriously harmful to health; damaging consequences for physical injuries caused by fake medicines; healthcare institutions that knowingly apply or sell counterfeit or inferior drugs, and their responsibilities according to criminal investigation; and those who facilitate illegal sales by providing mailing and advertising services. (Click here for more - Chinese Language)
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.